PFE Financial Facts
Cost of sales: 2.65BLess: Net income attributable to noncontrolling interests: 15M
See Full Income Statement
Long-term debt: 31.48B
Accounts receivable, less allowance for doubtful accounts: 12.74B
See Full Balance Sheet
Earnings History for Pfizer Inc. (PFE)
|
Expand Research on PFE
| Next EPS Date | 7/30/13 *Est. | EPS Growth Rate | -6.9% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +5.0% | Revenue Growth Rate | -12.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | -1.2% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/2/10  |
 |
Q310 | $0.54 | $0.51 | +$0.03 | N/A | N/A | N/A / N/A | N/A | +66.3% | Details |
| 2/1/11 |
|
Q410 | $0.47 | $0.46 | +$0.01 | $17.56B | $16.97B | N/A / N/A | = | +60.8% | Details |
| 11/1/11 |
|
Q311 | $0.62 | $0.55 | +$0.07 | $3.74B | $16.43B | $0.63 / $17.02B | = | +52.1% | Details |
| 7/31/12 |
|
Q212 | $0.62 | $0.54 | +$0.08 | $15.1B | $14.9B | $0.57 / $15.2B | = | +23.6% | Details |
| 1/29/13 |
|
Q412 | $0.47 | $0.44 | +$0.03 | $15.1B | $14.4B | N/A / N/A | = | +9.2% | Details |
| 5/3/11 |
|
Q111 | $0.60 | $0.59 | +$0.01 | $16.5B | $16.65B | N/A / N/A | = | +39.4% | Details |
| 5/1/12 |
|
Q112 | $0.58 | $0.56 | +$0.02 | $15.4B | $15.47B | $0.54 / $15.3B | = | +27.9% | Details |
| 11/1/12 |
Q312 | $0.53 | $0.53 | $0.00 | $14B | $14.64B | $0.57 / $14.69B | = | +17.8% | Details |
